undamentalytics Newsletter

Merriman Ronald: insider trades

Director at 3 companies we cover. No open-market purchases and 19 sales not made under a pre-set plan, reported from August 2, 2010 to June 15, 2021.

What happened after Merriman Ronald’s sales?

After their sales, the shares moved +6.1% against the index over 12 months on average (a negative figure means selling was the right call); 53% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Merriman Ronald: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 19 −2.0% −4.2% 63% 10 −0.71 0.49 No reliable evidence
Sales, 12 months after the report 19 +6.1% −0.5% 53% 10 0.63 0.54 No reliable evidence
Sales, 12 months after the trade 19 +5.4% −2.0% 53% 10 0.55 0.59 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Haemonetics Corp HAE —09November 8, 2010May 24, 2017
Realty Income O —07August 2, 2010June 15, 2021
Pentair PNR —03May 23, 2012February 3, 2014

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
June 15, 2021June 11, 2021 O Sale $280,200 −5.4%+10.8%+7.8%
May 28, 2019May 24, 2019 O Sale $424,320 +3.7%−26.9%−26.1%
May 24, 2017May 22, 2017 HAE Sale $704,567 +0.5%+107.1%+105.4%
May 24, 2017May 22, 2017 HAE Sale $330,463 +0.5%+107.1%+105.4%
August 19, 2016August 17, 2016 HAE Sale $152,403 +7.3%+0.9%+5.0%
August 18, 2016August 17, 2016 O Sale $166,700 −17.8%−23.1%−25.4%
February 19, 2016February 17, 2016 O Sale $253,163 −6.0%−16.9%−19.5%
March 5, 2015March 4, 2015 O Sale $252,200 −7.6%+25.5%+25.8%
March 5, 2015March 4, 2015 HAE Sale $624,500 −4.2%−20.8%−22.2%
August 14, 2014August 12, 2014 HAE Sale $486,363 −2.3%−0.5%−2.0%
February 3, 2014January 30, 2014 PNR Sale $1,493,600 −5.3%−31.1%−29.3%
May 1, 2013April 29, 2013 PNR Sale $540,500 +10.4%+22.3%+16.7%
November 21, 2012November 19, 2012 HAE Sale $81,628 −7.4%−30.6%−33.4%
May 23, 2012May 22, 2012 PNR Sale $505,344 −4.3%+11.1%+10.6%
May 9, 2012May 7, 2012 HAE Sale $71,460 −4.6%−13.9%−10.9%
March 20, 2012March 20, 2012 O Sale $76,020 +10.4%+8.6%+8.9%
May 10, 2011May 9, 2011 HAE Sale $710,723 −1.1%+2.9%+1.8%
November 8, 2010November 4, 2010 HAE Sale $406,770 −6.6%−4.3%−2.1%
August 2, 2010August 2, 2010 O Sale $245,175 +0.7%−12.1%−13.4%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Merriman Ronald traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.